• Advertise
  • Contact Us
  • Daily The Business
  • Privacy Policy
Friday, December 5, 2025
Daily The Business
  • Login
No Result
View All Result
DTB
No Result
View All Result
DTB

FDA-Only Products: Punjab’s Centralised Tender Conditioning Ignites Controversy

May 31, 2024
in Business
FDA-Only Products: Punjab’s Centralised Tender Conditioning Ignites Controversy
Share on FacebookShare on TwitterWhatsapp

The government of Punjab has conditioned the cardiac disposables and consumables products only FDA-approved and disqualified a majority of the European, Chinese, and Japanese brands cardiac suppliers also approved by the Drug Regulatory Authority Pakistan (DRAP).

According to a recent tender document of the Specialized Healthcare and Medical Education Department Government of the Punjab, the provincial government has sought invitation bids from interested parties having the ability to supply FDA-approved disposables and consumables required during the treatment of heart-related surgeries in the public hospitals of Punjab.

According to other DRAP-approved cardiac suppliers, the Punjab government’s recent centralised tender conditioning of FDA-only products would not only disqualify a majority of DRAP-approved suppliers for cardiology supplies but has ignited controversy. The decision has also raised serious concerns over fair competition and equal opportunity.

The DRAP, established under the DRAP Act, 2012, serves as a regulatory body ensuring stringent quality standards for healthcare products in Pakistan. However, despite DRAP approval, government of Punjab’s condition to require US FDA approval only, creating a dispute over procurement practices.

Total proposed budget of the tender is Rs15 billion based on the tender estimate price, which is likely to go to Rs18-20 billion. Out of this budget, Rs12 billion will be awarded to FDA brands and the remaining budget will be for the rest of the companies including CE and FDA both.

There is a serious price difference between the US brands and other brands. For instance, Balloon Catheter FDA Brands prices range between Rs14,500-17,000 as other CE Marked Drap Registered products range between Rs9,000-10,000. So only this product can eat extra budget of Rs400 million let alone other products such as guide wire and stents where numbers can go far beyond, while this extra amount can be spent on the treatment of other patients.

The recent move by the Specialized Healthcare Punjab to centralise tenders for cardiology supplies across seven major institutes, including the Punjab Institute of Cardiology and Multan Institute of Cardiology, has further exacerbated tensions. Typically, tenders are issued individually by each hospital, allowing equal opportunities for participation. However, the centralised tender process has been criticised for its discriminatory pre-qualification and technical requirements that favour only a handful of companies.

Key grievances include the imposition of additional security deposits, with companies already having submitted bids and deposits for individual hospital tenders. The requirement for past experience specifically in Punjab-based teaching hospitals and the insistence on US FDA-approved products further limits competition and excludes new entrants from the bidding process.

Moreover, concerns have been raised about the transparency and fairness of the tender process, with allegations of malpractice and favouritism towards certain brands. The decision to disqualify other DRAP-approved suppliers in favour of US FDA-approved brands has sparked outrage among industry stakeholders, who view it as a deliberate attempt to monopolise the market and limit patient choice.

As the controversy continues to unfold, stakeholders urge the Punjab government to reconsider its tender policies and prioritise transparency, fairness, and healthcare accessibility.

When contacted, Dr Asim Javed, member committee of the Specialized Healthcare and Medical Education Department Government of Punjab, he said that the provincial government has taken this decision in the best interests of the patients, adding that cardiac-related issues are serious and the government aims to provide them the best medical care. He further said that other suppliers are not disqualified as they can still provide other supplies, however, the government in the tender has conditioned some cardiac supplies with FDA approved. He rejected the notion that it would negatively affect the fair competition principle, saying there are five to six such suppliers.

He said that the decision has been taken after detailed deliberation keeping in view the welfare of the patients and suppliers will ensure required supplies.

This correspondent tried to contact Special Secretary Specialized Healthcare and Medical Education Department Government of Punjab and Dr Hafiz Shahzad Latif, additional secretary of the department by email and telephone but they did not respond.

SOURCE: BUSINESS RECORDER

Tags: CentralisedConditioningControversyFDAOnlyIgnitesProductsPunjabsTender
Share15Tweet10Send
Previous Post

Pakistan’s FY25 budget to be presented on June 10, sources say

Next Post

Hong Kong stocks end week with a loss

Related Posts

Bullish momentum at bourse, KSE-100 gains over 1,100 points in early trade
Business

Bullish momentum at bourse, KSE-100 gains nearly 900 points during intra-day

December 5, 2025
World’s top solar maker says local manufacturing not yet viable in Pakistan
Business

World’s top solar maker says local manufacturing not yet viable in Pakistan

December 5, 2025
US stocks lower after mixed jobs data
Business

US stocks lower after mixed jobs data

December 4, 2025
Saudi Arabia extends term for $3bn deposit placed with Pakistan for another year
Business

Saudi Arabia extends term for $3bn deposit placed with Pakistan for another year

December 4, 2025
Pakistan, Kyrgyzstan sign agreements to strengthen bilateral cooperation
Business

Pakistan, Kyrgyzstan sign agreements to strengthen bilateral cooperation

December 5, 2025
Intra-day update: rupee records gain against US dollar
Business

Intra-day update: rupee records gain against US dollar

December 4, 2025

Popular Post

  • FRSHAR Mail

    FRSHAR Mail set to redefine secure communication, data privacy

    126 shares
    Share 50 Tweet 32
  • How to avoid buyer’s remorse when raising venture capital

    33 shares
    Share 337 Tweet 211
  • Microsoft to pay off cloud industry group to end EU antitrust complaint

    54 shares
    Share 22 Tweet 14
  • Capacity utilisation of Pakistan’s cement industry drops to lowest on record

    47 shares
    Share 19 Tweet 12
  • SingTel annual profit more than halves on $2.3bn impairment charge

    47 shares
    Share 19 Tweet 12
American Dollar Exchange Rate
  • Advertise
  • Contact Us
  • Daily The Business
  • Privacy Policy
Write us: info@dailythebusiness.com

© 2021 Daily The Business

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

No Result
View All Result
  • Advertise
  • Contact Us
  • Daily The Business
  • Privacy Policy

© 2021 Daily The Business

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.